CT/GP/025

Organization name

GeneProof a.s.

SRN

CZ-MF-000002370

Manufacturer status

Active

1 warning recorded — scroll inside the panel to see all entries.

• CW010

  EUDAMED did not publish a description for this code.

Primary placement in Czechia; available across 12 countries total.

Trade name

not provided

UDI-DI code

08595696300241

Basic UDI-DI

859569630013QA

Reference / catalog number

CT/GP/025

Issuing entity

GS1

Risk category

IVDR Class C

Applicable legislation

IVDR [Regulation (EU) 2017/746 on in vitro diagnostic medical devices]

Status

On the market

Quantity

1

Additional product description

The intended purpose of the device is related to the medical context and clinical conditions under which the device may be used. Chlamydia trachomatis infection can cause cervicitis, urethritis, and proctitis. In women, the infection can cause pelvic inflammatory disease, tubal factor infertility, ectopic pregnancy, and chronic pelvic pain. In newborns, untreated infection can cause pre-term delivery, ophthalmia neonatorum (conjunctivitis), and pneumonia. The GeneProof Chlamydia trachomatis PCR Kit is an in vitro nucleic acid amplification test intended for detection of Chlamydia trachomatis by real-time polymerase chain reaction (PCR) method. The clinical specimens used for the detection are urine, swabs, and sperm. The GeneProof Chlamydia trachomatis PCR Kit can be used in combination with a manual or automated extraction system. The kit is designed for human in vitro diagnostics and provides qualitative detection. The kit is intended for diagnostics and aid to diagnosis, and it is designed for professional use in laboratories with trained staff.

Additional information URL

https://www.geneproof.com/ifu

Clinical sizes

No clinical sizes registered for this device.

• W0105010117CHLAMYDIA TRACHOMATIS DETECTION BY NA REAGENTS

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification